Cancer Patients Receiving Covid mRNA Shots Show Dramatically Longer Survival

The same Nobel-winning mRNA technology that helped curb the Covid-19 pandemic may be poised to transform cancer care.
Morningstar

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 14, 2025 / Ainos, Inc. (Nasdaq:AIMD, AIMDW) ("Ainos" or the "Company"), pioneer of low-dose oral interferon therapeutics, today announced significant ...

A Google AI model has discovered a promising new cancer treatment method, described as 'a milestone for AI in science'

When you buy through links on our articles, Future and its syndication partners may earn a commission.
Business Insider

Ainos advances Veldona oral interferon drug platform

Ainos (AIMD) announced progress in advancing its oral interferon drug platform, Veldona in the rare disease space. The Taiwan FDA has approved the company’s clinical trial for human immunodeficiency ...

Five key genes linked to severe COVID-19 found, suggesting drug targets

Five key genes are linked with the most severe form of COVID-19, scientists said on Friday, in research that also pointed to several existing drugs that could be repurposed to treat people who risk ...
Southeast Missourian

New drug shows promise for treating MS, Chron's disease

An experimental drug shows promise as an effective new approach for treating multiple sclerosis and the intestinal ailment Crohn's disease. In preliminary tests, the new drug Antegren dramatically ...